Skip to main content

News

By Healthcare Finance Staff | 11:25 am | October 14, 2014
Tech giant Google is trying out the telehealth waters with a video-based platform that connects consumers searching online for health data with physicians.
By Healthcare Finance Staff | 11:12 am | October 14, 2014
It's almost game day for the second season of ACA insurance exchanges, and insurers need to get ready to handle all sorts of consumer inquiries and administrative tasks.
By Healthcare Finance Staff | 11:04 am | October 14, 2014
The competitiveness of America's state and regional health insurance markets is once again under question as patients and providers demand greater value propositions from payers.
By Healthcare Finance Staff | 03:03 pm | October 13, 2014
A new molecular diagnostic approved by Medicare and Medicaid is among the first non-invasive alternatives to colonoscopies, a potential boon for patients and payers but also a new piece of the personalization puzzle to manage.
By Healthcare Finance Staff | 12:42 pm | October 13, 2014
Cost-sharing in traditional Medicare is on the rise, and benefit designs in Medicare drug plans are changing.
By Faith Mitchell | 11:56 am | October 13, 2014
Beginning in the 1970s, the conversion of nonprofit healthcare organizations to for-profit status created many new foundations. Soon, in the wake of the Affordable Care Act, even more "conversion" foundations will be created, resulting from what some have termed a "merger frenzy."
By Anthony Brino | 11:20 am | October 13, 2014
As healthcare's trade winds blow towards more consolidation, some nonprofit health systems are taking a new business turn, while trying to continue traditional charitable missions.
By Julie Munro | 11:06 am | October 13, 2014
For those in the medical tourism industry, the issue of "surrogacy tourism" or commercial surrogacy is not an issue of morality. Whatever one believes, there is a need for surrogacy services and people will take chances with the law in order to have children.
By Healthcare Finance Staff | 01:08 pm | October 10, 2014
As more providers adpot robotic surgery technology, more information on comparative effectiveness is raising questions about costs and benefits.
By Healthcare Finance Staff | 01:03 pm | October 10, 2014
The new hepatitis C treatment Sovaldi has driven debate over drug costs for close to a year, but it's also been a case study in access and coverage in public payer programs.